Caplin, M. E. (2021). Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients? Elsevier.
Chicago Style (17th ed.) CitationCaplin, Martyn E. Can the Peptide Receptor Radionuclide Therapy [177Lu]Lu-DOTA-TATE Provide a Net Benefit for NET patients? Elsevier, 2021.
MLA (8th ed.) CitationCaplin, Martyn E. Can the Peptide Receptor Radionuclide Therapy [177Lu]Lu-DOTA-TATE Provide a Net Benefit for NET patients? Elsevier, 2021.
Warning: These citations may not always be 100% accurate.